Two Sigma Investments’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-83,099
| Closed | -$26.2K | – | 3173 |
|
|
2025
Q1 | $26.2K | Buy |
83,099
+11,980
| +17% | +$3.78K | ﹤0.01% | 3026 |
|
|
2024
Q4 | $21.3K | Buy |
+71,119
| New | +$21.3K | ﹤0.01% | 3037 |
|
|
2024
Q2 | – | Sell |
-20,231
| Closed | -$80.5K | – | 2985 |
|
|
2024
Q1 | $80.5K | Buy |
+20,231
| New | +$80.5K | ﹤0.01% | 2774 |
|
|
2022
Q1 | – | Sell |
-65,086
| Closed | -$43K | – | 2631 |
|
|
2021
Q4 | $43K | Buy |
65,086
+18,458
| +40% | +$12.2K | ﹤0.01% | 2474 |
|
|
2021
Q3 | $43K | Sell |
46,628
-210,190
| -82% | -$194K | ﹤0.01% | 2450 |
|
|
2021
Q2 | $306K | Sell |
256,818
-406,383
| -61% | -$484K | ﹤0.01% | 2121 |
|
|
2021
Q1 | $1.07M | Buy |
663,201
+616,026
| +1,306% | +$992K | ﹤0.01% | 1562 |
|
|
2020
Q4 | $98K | Buy |
+47,175
| New | +$98K | ﹤0.01% | 1907 |
|